Indivior Plc INDV

NAS: INDV | ISIN: GB00BN4HT335 7/05/2024

17,70 USD (-2,48%)

(-2,48%) 7/05/2024

Grafiek Indivior Plc

Grafiek Indivior Plc

1 dag1d -2,48%
1 week1w 0,40%
1 maand1m -16,86%
3 maanden3m -0,51%
6 maanden6m -8,27%
1 jaar1j -22,67%
5 jaar5j -22,67%

Indivior Plc in het nieuws

Toon enkel gratis nieuws

25 april 2024 · Indivior Announces Q1 2024 Financial Results · Persbericht

11 maart 2024 · Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone · Persbericht

29 februari 2024 · Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation · Persbericht

22 februari 2024 · Indivior Announces Q4 / FY 2023 Financial Results · Persbericht

9 november 2023 · Indivior Announces Q3 2023 Financial Results · Persbericht

11 oktober 2023 · Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals · Persbericht

26 september 2023 · Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada · Persbericht

21 augustus 2023 · Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims · Persbericht

27 juli 2023 · Indivior Announces Q2/H1 2023 Financial Results · Persbericht

Profiel Indivior Plc

CEO: Shaun Thaxter

Aandelen Indivior Plc

Effecten: 135,34 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe